图 书 馆
控释和纳米药物中的生物大分子：聚丙交酯-乙交酯微球和纳米微球Biomacromolecules in controlled release and nanomedicine: poly (lactide-co-glycolide) micro and nanospheres |
|
| 课程网址: | http://videolectures.net/nib_stevanovic_nanospheres/ |
| 主讲教师: | Magdalena Stevanović |
| 开课单位: | 塞尔维亚科学和艺术学院技术科学研究所 |
| 开课时间: | 2012-02-06 |
| 课程语种: | 英语 |
| 中文简介: |  |
| 课程简介: | Biomacromolecules such as poly (glycolic acid), poly (lactic acid), their copolymers and other polyesters have been used in a number of clinical applications. The major applications include drug delivery systems, tissue engineering applications, resorbable sutures and orthopaedic fixation devices. Among the families of synthetic polymers, the polyesters have been attractive for these applications because of their ease of degradation by hydrolysis of ester linkage, degradation products being resorbed through the metabolic pathways and the potential to tailor the structure to alter degradation rates. Poly(lactide‐co‐glycolide) (PLGA) or poly(D,L‐lactide) (PDLLA) particles allow the encapsulation of medicaments within the polymer matrix, and the crucial requirements for the controlled and balanced release of the medicament in the body are their ideal spherical shape and narrow size distribution. The size and shape of particles play the key role in their adhesion and interaction with the cell. Polymer degradation, also, plays a key role in medicament release from sustained release polyester systems, therefore in order to elucidate the mechanism governing release, it appears essential to analyze the in vitro degradation behavior of these devices. Different medicaments (water soluble vitamins, protein (horseradish peroxidase‐HRP), silver nanoparticles) have been successfully encapsulated into polyester micro and nanospheres thus creating nanoparticles with various morphological characteristic depending of the concentration of the active substance. In vitro degradation process and release tests, cytotoxicity, labeling polyester particles by 99mTc and biodistribution of PLGA nanoparticles without and with encapsulated medicament were examined. PLGA nanospheres with encapsulated ascorbic acid exhibit prolonged blood circulation accompanied by time dependent reduction in lung, liver and spleen, and addition in kidney, stomach and intestine. The obtained results indicate that neither PLGA nanospheres nor PLGA/ascorbic acid 85/15% nanoparticles significantly affected the viability of the HepG2 cells. HRP‐loaded PDLLA spheres were successfully prepared by the modified precipitation method that was previously applied for blank PDLLA and PLGA nanospheres. The HRP‐loaded microspheres have been successfully formulated with spherical morphology, suitable particle size, high protein encapsulation efficiency and good protein stability. Silver nanoparticles were prepared by modified chemical reduction method with saccharide as reducing agent and with poly (α, γ, L‐glutamic acid) as capping agent and were additionaly encapsulated within PLGA particles to ensure their release and therefore the antimicrobial effect over an extended period of time. The samples were characterized by X‐ray diffraction, scanning electron microscopy, stereological analysis, transmission electron microscopy, ultraviolet spectroscopy, instant thin layer chromatography, differential scanning calorimetry, fourier‐transform infrared spectroscopy and zeta potential measurements. |
| 关 键 词: | 控制释放的机制; 聚合物降解; 纳米颗粒 |
| 课程来源: | 视频讲座网 |
| 数据采集: | 2021-12-02：zkj |
| 最后编审: | 2021-12-02：zkj |
| 阅读次数: | 59 |